The TGF-β for Immuno-Oncology Drug Development Summit aims to improve the efficacy of TGF-β monotherapy or combination therapies by utilizing clinically validated biomarkers and understanding TGF-β biology. The event provides insights into patient identification and clinical challenges for precision medicine.
Timings09:00 AM-06:00 PM (expected)
Entry FeesCheck Official Website
Estimated Turnout100 - 500
DelegatesBased on previous editions
EditionsJun 2023, San Francisco
Jan 2022, Online
+2 more editions
Next edition likely in Dec 2023
Claim this event
Queries about the event? Ask Organizer
457 Total Events • 136 Followers
How did you participate in this event?
Followers [ Users who have shown interest for this Event ] Join Community Invite